High-sensitivity C-reactive protein is associated with hippocampus volume in nondementia patients with type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 60, Issue 4, 2011, Pages 460-466

  Anan, Futoshi ^a,b   Masaki, Takayuki ^b   Shimomura, Tsuyoshi ^b   Fujiki, Minoru ^b   Umeno, Yoshikazu ^a   Eshima, Nobuoki ^b   Saikawa, Tetsunori ^b   Yoshimatsu, Hironobu ^b  

^a OITA RED CROSS HOSPITAL   (Japan)

^b OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

AGE; AGED; ARTICLE; BODY MASS; BRAIN ATROPHY; BRAIN SIZE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COGNITION; COMPUTER ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HEMOGLOBIN BLOOD LEVEL; HIGH SENSITIVITY C REACTIVE PROTEIN BLOOD LEVEL; HIPPOCAMPUS; HIPPOCAMPUS VOLUME; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTERMETHOD COMPARISON; JAPANESE; MALE; MINI MENTAL STATE EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGED; BODY MASS INDEX; BRAIN; C-REACTIVE PROTEIN; COGNITION; DIABETES MELLITUS, TYPE 2; FEMALE; HEART RATE; HIPPOCAMPUS; HUMANS; HYPERTENSION; IMAGE PROCESSING, COMPUTER-ASSISTED; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; REGRESSION ANALYSIS;

EID: 79952985772     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.04.002     Document Type: Article

References (50)

1. Goldstein L.B., Adams R., and Becker K. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association Circulation 103 2001 163 182 (Pubitemid 32050453)
2. Hébert R., Lindsay J., and Verreault R. Vascular dementia: incidence and risk factors in the Canadian study of health and aging Stroke 31 2000 1487 1493 (Pubitemid 30437492)
3. Reaven G.M. Banting lecture 1988: role of insulin resistance in human disease Diabetes 37 1988 1595 1607 (Pubitemid 19004941)
4. Reagan L.P. Insulin signaling effects on memory and mood Curr Opin Pharmacol 7 2007 633 637 (Pubitemid 350177560)
5. Ott A., Stolk R.P., and van Harskamp F. Diabetes mellitus and the risk of dementia: the Rotterdam study Neurology 53 1999 1937 1942
6. Peila R., Rodriguez B.L., and Launer L.J. Honolulu-Asia Aging Study. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study Diabetes 51 2002 1256 1262 (Pubitemid 34438377)
7. Pearson T.A., Mensah G.A., and Alexander R.W. Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 2003 499 511 (Pubitemid 36158056)
8. Teunissen C.E., van Boxtel M.P., and Bosma H. Inflammation markers in relation to cognition in a healthy aging population J Neuroimmunol 134 2003 142 150 (Pubitemid 36054172)
9. Yaffe K., Lindquist K., and Penninx B.W. Inflammatory markers and cognition in well-functioning African-American and white elders Neurology 134 2003 76 80 (Pubitemid 36818750)
10. Ravaglia G., Forti P., and Maioli F. Blood inflammatory markers and risk of dementia: the Conselice Study of Brain Aging Neurobiol Aging 28 2007 1810 1820 (Pubitemid 47539699)
11. Press G.A., Amaral D.G., and Squire L.R. Hippocampus abnormalities in amnesic patients revealed by high-resolution magnetic resonance imaging Nature 341 1989 54 57 (Pubitemid 19220655)
12. Baxendale S. Amnesia in temporal lobectomy patients: historical perspective and review Seizure 7 1998 15 24 (Pubitemid 28121945)
13. Smith A.D., Jobst K.A., and Edmonds Z. Neuroimaging and early Alzheimer's disease Lancet 348 1996 829 830
14. Jack C.R., Petersen R.C., and Xu Y. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease Neurology 51 1998 993 999 (Pubitemid 28473390)
15. De Toledo-Morrell L., Goncharova I., and Dickerson B. From healthy aging to early Alzheimer's disease: in vivo detection of entorhinal cortex atrophy Ann N Y Acad Sci 911 2000 240 253 (Pubitemid 30462086)
16. De Santi S., de Leon M.J., and Rusinek H. Hippocampal formation glucose metabolism and volume losses in MCI and AD Neurobiol Aging 22 2001 529 539 (Pubitemid 32607736)
17. Hirata Y., Matsuda H., and Nemoto K. Voxel-based morphometry to discriminate early Alzheimer's disease from controls Neurosci Lett 382 2005 269 274 (Pubitemid 40733634)
18. Liao D., Sloan R.P., and Cascio W.E. Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study Diabetes Care 21 1998 2116 2122 (Pubitemid 28549160)
19. Mancia G., De Backer G., and Dominiczak A. ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension J Hypertens 25 2007 1751 1762 (Pubitemid 47356612)
20. Friedwald W.T., Levi R.I., and Fredrickson D.C. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge Clin Chem 18 1972 499 502
21. Matthews D.R., Hosker J.P., and Rudenski A.S. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419 (Pubitemid 15018832)
22. Rifai N., Tracy R.P., and Ridker P.M. Clinical efficacy of an automated high-sensitivity C-reactive protein assay Clin Chem 45 1999 2136 2141
23. Frohlich M., Imhof A., and Berg G. Association between C-reactive protein and features of the metabolic syndrome: a population-based study Diabetes Care 23 2000 1835 1839
24. Folstein M.F., Folstein S.E., and McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
25. Ashburner J., and Friston K.J. Voxel-based morphometry: the methods NeuroImage 11 2000 805 821
26. Ashburner J., and Friston K. Multimodal image coregistration and partitioning-a unified framework NeuroImage 6 1997 209 217 (Pubitemid 27488452)
27. Metz C.E., Herman B.A., and Roe C.A. Statistical comparison of two ROC-curve estimates obtained from partially-paired datasets Med Decis Making 18 1998 110 121 (Pubitemid 28041647)
28. Anan F., Masaki F., and Shimomura T. Abdominal visceral fat accumulation is associated with hippocampal volume in non-dementia patients with type 2 diabetes mellitus NeuroImage 49 2010 57 62
29. Yudkin J.S., Stehouwer C.D., and Emeis J.J. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19 1999 972 978 (Pubitemid 29177345)
30. Festa A., D'Agostino R. Jr, and Howard G. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS) Circulation 102 2000 42 47 (Pubitemid 30430551)
31. Wagenknecht L.E., Mayer E.J., and Rewers M. The Insulin Resistance Atherosclerosis Study (IRAS): objectives, design and recruitment results Ann Epidemiol 5 1995 464 471
32. Arner P. Insulin resistance in type 2 diabetes: role of fatty acids Diabetes Metab Res Rev 18 2002 S5 S9
33. Mittelmanm S.D., Van Citters G.W., and Kim S.P. Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced β-cell response Diabetes 49 2000 2116 2125
34. Bertin E., Nguyen P., and Guenounou M. Plasma levels of tumor necrosis factor-alpha (TNF-α) are essentially dependent on visceral fat amount in type 2 diabetic patients Diabetes Metab 26 2000 178 182 (Pubitemid 30435762)
35. Katsuki A., Sumida Y., and Murashima S. Serum levels of tumor necrosis factor-α are increased in obese patients with noninsulin-dependent diabetes mellitus J Clin Endocrinol Metab 83 1998 859 862 (Pubitemid 28496458)
36. Hotta K., Funahashi T., and Bodkin N.L. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys Diabetes 50 2001 1126 1133 (Pubitemid 32374544)
37. Weyer C., Funahashi T., and Tanaka S. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia J Clin Endcrinol Metab 86 2001 1930 1935 (Pubitemid 32472900)
38. McTernan P.G., McTernan C.L., and Chetty R. Increased resistin gene and protein expression in human abdominal adipose tissue J Clin Endocrinol Metab 87 2002 2407
39. Steppan C.M., Bailey S.T., and Bhat S. The hormone resistin kinks obesity to diabetes Nature 409 2001 307 312 (Pubitemid 32151228)
40. Ferri C., Croce G., and Cofini V. C-reactive protein; interaction with the vascular endothelium and possible role in human atherosclerosis Curr Pharm Des 13 2007 1631 1645 (Pubitemid 46979719)
41. Jialal I., Devaraj S., and Singh U. C-reactive protein and the vascular endothelium: implications for plaque instability J Am Coll Cardiol 47 2006 1379 1381
42. Uchikado H., Akiyama H., and Kondo H. Activation of vascular endothelial cells and perivascular cells by systemic inflammation-an immunohistochemical study of postmortem human brain tissues Acta Neuropathol 107 2004 341 351 (Pubitemid 38477361)
43. Dore S., Kar S., and Rowe W. Distribution and levels of [125I]IGF-I, [125I]IGF-II and [125I]insulin receptor binding sites in the hippocampus of aged memory-unimpaired and -impaired rats Neuroscience 80 1997 1033 1040 (Pubitemid 27359790)
44. Park C.R. Cognitive effects of insulin in the central nervous system Neurosci Biobehav Rev 25 2001 311 323 (Pubitemid 32624374)
45. Park C.R., Seeley R.J., and Craft S. Intracerebroventricular insulin enhances memory in a passive-avoidance task Physiol Behav 68 2000 509 514 (Pubitemid 30129236)
46. Zhao W., Chen H., and Moore E. Brain insulin receptors and spatial memory J Biol Chem 274 1999 34893 34902
47. McEwen B.S., and Reagan L.P. Glucose transporter expression in the central nervous system: relationship to synaptic function Eur J Pharmacol 490 2004 13 24 (Pubitemid 38482158)
48. Young S.E., Mainous A.G. III, and Carnemolla M. Hyperinsulinemia and cognitive decline in a middle-aged cohort Diabetes Care 29 2006 2688 2693 (Pubitemid 44912200)
49. Gavras H.P. Issues in hypertension: drug tolerability and special populations Am J Hypertens 14 2001 231S 236S (Pubitemid 32607302)
50. Lender D., Arauz-Pacheco C., and Breen L. A double blind comparison of the effects of amlodipine and enalapril on insulin sensitivity in hypertensive patients Am J Hypertens 12 1999 298 303 (Pubitemid 29147356)